movement disorders:孤立的快速眼动睡眠,语言异常或可提示认知障碍

2022-07-13 Freeman MedSci原创

语言学特征可能为检测iRBD受试者中由前驱神经变性引起的认知能力下降提供了可靠的自动方法

目前正在开发帕金森病(PD)等神经退行性疾病。因为引入疾病修正治疗的最佳时间段是神经退行性疾病的前驱阶段,所以找到这一疾病阶段的诊断和进展性生物标志物至关重要。孤立的快速眼动睡眠行为障碍(iRBD)是一种寄生性失眠症,其特点是与快速眼动睡眠期间肌肉失张力有关的梦境行动行为。

图1: 论文封面图

多项研究认为,iRBD是突触蛋白病的前驱标志,有70%至80%的风险发展为明显的神经退行性疾病,特别是PD或路易体痴呆(DLB)。

iRBD患者认知能力下降的模式和严重程度可以预测突触核蛋白病的亚型。认知恶化更能预测DLB的发展,而在那些将发展为PD或保持无突触蛋白病的iRBD患者中,通常会观察到认知性能的未改变。

有趣的是,认知能力的细微缺陷甚至影响到那些不符合轻度认知障碍(MCI)标准的iRBD患者。对语言功能(MCI的一个核心认知领域)的调查和细微的认知衰退研究提供了关于几种神经退行性疾病中认知改变的独特模式的宝贵信息。

事实上,在PD和其他基底神经节疾病中普遍观察到语言异常,如句法复杂性受限和词汇-语义理解能力。到目前为止,还没有研究对iRBD患者潜在的前驱语言障碍进行研究。

如今,数字技术的进步为语言处理提供了新的可能性。自动语音识别(ASR)和自然语言处理(NLP)用于分析和分类语言,在智能手机等广泛的设备上广泛使用。因此,基于自发语音的生物标志物可能大大受益于在实验室环境之外获得的自动数据分析,并有可能适用于大量人群。然而,突触神经病患者不仅可能出现认知上的改变,还可能出现运动性言语障碍,这两者都可能给自动识别和NLP技术带来困难,无法正确转录和注释语音。此外,用于话语分析的各种自发话语可能给MCI患者带来进一步的困难。

藉此,捷克布拉格科技大学的Martin Šubert等人,评估在不同类型的自发话语中检查的语言障碍,是否能在iRBD患者和有或没有MCI的PD患者中发现。还探索是否可以通过使用现有的ASR和NLP技术,以完全自动化的方式进行前驱和表现的突触神经病的话语分析。

他们招募了139名捷克本地参与者,包括40名无MCI的iRBD和14名有MCI的iRBD,与40名无MCI的PD、15名有MCI的PD和30名健康对照对象进行比较。

对自发的话语和故事叙述进行了转录和语言学上的注释。进行了定量分析,计算了三种语言学特征。人工注释与全自动注释进行了比较。

 

图2:论文结果图

他们发现: 与对照组相比,iRBD患者的内容密度较差,反映了内容词和修饰词的减少。患有MCI的PD和iRBD亚组都表现出较少出现独特的词和较多的n-grams重复,表明词汇的丰富性较差。

自发话语任务显示了没有MCI的iRBD的语言障碍,曲线下面积为0.72,而故事叙述任务更好地反映了MCI的存在,将PD和iRBD亚组的MCI与对照组区分开,曲线下面积高达0.81。

此外,手动和自动计算的结果之间有很强的相关性。

他们发现:语言学特征可能为检测iRBD受试者中由前驱神经变性引起的认知能力下降提供了可靠的自动方法,为未来的治疗试验提供了关键结果。

 

原文出处:
Šubert M, Šimek M, Novotný M, et al. Linguistic Abnormalities in Isolated Rapid Eye Movement Sleep Behavior Disorder. _Movement Disorders_. Published online July 7, 2022:mds.29140. doi:[10.1002/mds.29140](https://doi.org/10.1002/mds.29140)

 

评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2023-04-20 zhouqu_8
  2. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-12-10 cmsvly

    #Disord#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-12-10 anminleiryan

    #ERS#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2023-04-21 cmj8wellington

    #Dis#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-14 yangjxjc

    #语言#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1738143, encodeId=635f1e38143d8, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 20 00:09:06 CST 2023, time=2023-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784527, encodeId=51341e845273d, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Dec 10 13:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878559, encodeId=04dd18e855935, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Sat Dec 10 12:09:06 CST 2022, time=2022-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077711, encodeId=d59720e771196, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fc52500170, createdName=12498cbcm00(暂无昵称), createdTime=Sat Apr 22 11:09:06 CST 2023, time=2023-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651131, encodeId=f1f3165113153, content=<a href='/topic/show?id=f0ed5206e22' target=_blank style='color:#2F92EE;'>#快速眼动睡眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52067, encryptionId=f0ed5206e22, topicName=快速眼动睡眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38ca24126060, createdName=DEXTER3147, createdTime=Mon Oct 31 09:09:06 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013923, encodeId=29cd201392342, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Apr 21 10:09:06 CST 2023, time=2023-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418234, encodeId=52dd1418234e8, content=<a href='/topic/show?id=a4719180605' target=_blank style='color:#2F92EE;'>#语言#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91806, encryptionId=a4719180605, topicName=语言)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c16b3335392, createdName=yangjxjc, createdTime=Thu Jul 14 04:09:06 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232301, encodeId=d76e1232301a0, content=踩一踩留个脚印,后面看, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/10/12/17a33053ae7e8e775b4c39d9bdcf120f.jpg, createdBy=13152459353, createdName=桐梓坡凯, createdTime=Wed Jul 13 20:36:06 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-13 桐梓坡凯

    踩一踩留个脚印,后面看

    0

相关资讯

Movement disorders:帕金森病:黑质中的铁沉积,如何随时间变化?

在开始使用多巴胺能药物治疗之前,黑质铁较低,然后在整个疾病过程中不断增加,直到晚期达到平稳

Cell:徐浩新/胡美钦/李平/王策等揭示帕金森病发病风险的新机制

该研究开辟了溶酶体 pH 调节的新方向,首次鉴定出溶酶体膜上的氢离子通道:TMEM175 是一种新型的氢离子激活的氢离子通道。

Movement disorders-帕金森病伴肌张力障碍与否,皮层和下丘脑有何改变?

运动皮层和STN场电位的频谱功率在重复肢体运动时有明显的不同。

Movement disorders:帕金森患者,糖尿病可加速其进展

T2DM与帕金森病的疾病进展速度有关,突出了这两种疾病之间的互动。

Movement disorders 同济大学;帕金森病:短链脂肪酸减少,或因肠-血屏障受损

PD患者的粪便和血浆SCFAs的改变与GBB受损有关,并可能因便秘而加重。

拓展阅读

BioScience Trends:帕金森病动物模型中的听力损伤可能与耳蜗传出纤维变化有关

帕金森病模型动物的耳蜗,尤其是其传出神经纤维系统,发生了早期且复杂的病理改变。

中医再亮剑!北京团队解密天麻钩藤饮:先救少突胶质细胞,再护神经元,帕金森“髓鞘-突触”双修复时代开启!

该研究首次将血清药物化学、单细胞转录组、网络药理学与类器官模型整合,阐明TGD“重塑神经元-少突胶质细胞互作”的新机制,为中医“祛风止颤”提供现代注解,也为全球PD复合药物研发贡献可复制的技术范式。

Lancet Neurology:硫唑嘌呤治疗早期帕金森病的概念验证试验,阴性主要终点下的性别差异信号与免疫调控启示

AZA-PD研究虽未支持硫唑嘌呤直接作为帕金森病的治疗选择,但它成功完成了概念验证,打开了通过调节外周免疫系统来干预帕金森病进程的研究大门。

2025帕金森病十大科学研究新进展 | 年终大盘点

神经科学论坛小编系统梳理2025年度最具影响力的十大科研进展,展示人类向帕金森病发起总攻的科学图景。

前沿快讯 | 情绪如何“震颤”?认知怎样“绊脚”?

安徽中医药大学王共强团队通过多模态研究,揭示消极情绪可加剧帕金森病、威尔森病患者震颤,认知负荷会恶化威尔森病患者步态,阐明情绪 - 认知 - 运动整合环路机制,为神经疾病精准干预提供新方向。

大脑“老化时钟”可预测帕金森病恶化速度

这种“异质性”为临床精准管理带来了巨大挑战,也使得旨在延缓甚至阻断疾病进程的新药临床试验举步维艰——为了在“平均”人群中检测出药物效果,往往需要招募成百上千的患者,耗时耗力且成功率低。

2025 共识建议:帕金森病认知障碍的诊断、评估和管理

国外神经内科相关专家小组(统称) · 2025-07-24